May 31, 2013
JMA Vice President Satoshi Imamura Meets Press The Japan Medical Association (JMA) on May 29 nudged Novartis Pharma to disclose the details of its ongoing internal investigation into the alleged involvement of former employees in independent trials for Diovan (valsartan),...read more